drugset / Trial / NCT01176760
Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The aim of this study is to investigate the role of transmission via the vagal nerve for the effect of glucose and Glucagon-like peptide-1 (GLP-1) in respect to insulin secretion. The hypothesis is that a great deal of the effects of GLP-1 is mediated via the nervous system and for this reason the investigators will research individuals with and without intact nervous supply.
Timeline
- Start
- 2009-08
- Primary completion
- 2011-10
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vildagliptin | Other / unclassified | 50 mg | — |
Indications
No indication recorded.